Simultaneous Detection of Clinically Relevant Mutations and Amplifications for Routine Cancer Pathology

Hadd, 2013, Targeted, high-depth, next-generation sequencing of cancer genes in formalin-fixed, paraffin-embedded and fine-needle aspiration tumor specimens, J Mol Diagn, 15, 234, 10.1016/j.jmoldx.2012.11.006 Pao, 2004, EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib, Proc Natl Acad Sci U S A, 101, 13306, 10.1073/pnas.0405220101 Said, 2013, P53 mutations in advanced cancers: clinical characteristics, outcomes, and correlation between progression-free survival and bevacizumab-containing therapy, Oncotarget, 4, 705, 10.18632/oncotarget.974 Romond, 2005, Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer, N Engl J Med, 353, 1673, 10.1056/NEJMoa052122 Lv, 2012, Correlation of EGFR, IDH1 and PTEN status with the outcome of patients with recurrent glioblastoma treated in a phase II clinical trial with the EGFR-blocking monoclonal antibody cetuximab, Int J Oncol, 41, 1029, 10.3892/ijo.2012.1539 Kato, 2010, Evaluation of HER2 gene amplification in invasive breast cancer using a dual-color chromogenic in situ hybridization (dual CISH), Pathol Int, 60, 510, 10.1111/j.1440-1827.2010.02553.x Shao, 2011, Epidermal growth factor receptor gene amplification and protein overexpression in basal-like carcinoma of the breast, Histopathology, 59, 264, 10.1111/j.1365-2559.2011.03921.x Moelans, 2011, Current technologies for HER2 testing in breast cancer, Crit Rev Oncol Hematol, 80, 380, 10.1016/j.critrevonc.2010.12.005 Schouten, 2002, Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification, Nucleic Acids Res, 30, e57, 10.1093/nar/gnf056 Dancey, 2012, The genetic basis for cancer treatment decisions, Cell, 148, 409, 10.1016/j.cell.2012.01.014 Bang, 2010, Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial, Lancet, 376, 687, 10.1016/S0140-6736(10)61121-X Gravalos, 2008, HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target, Ann Oncol, 19, 1523, 10.1093/annonc/mdn169 Pazo Cid, 2013, Advanced HER2-positive gastric cancer: current and future targeted therapies, Crit Rev Oncol Hematol, 85, 350, 10.1016/j.critrevonc.2012.08.008 Tanner, 2005, Amplification of HER-2 in gastric carcinoma: association with Topoisomerase IIalpha gene amplification, intestinal type, poor prognosis and sensitivity to trastuzumab, Ann Oncol, 16, 273, 10.1093/annonc/mdi064 Han, 2013, Targeted sequencing of cancer-related genes in colorectal cancer using next-generation sequencing, PLoS One, 8, e64271, 10.1371/journal.pone.0064271 Moelans, 2009, HER-2/neu amplification testing in breast cancer by multiplex ligation-dependent probe amplification in comparison with immunohistochemistry and in situ hybridization, Cell Oncol, 31, 1 Iglewicz B, Hoaglin DC: How to Detect and Handle Outliers. ed 16. Milwaukee, WI, ASQC Quality Press, 1993 Gan, 2008, The EGFRvIII variant in glioblastoma multiforme, J Clin Neurosci, 16, 748, 10.1016/j.jocn.2008.12.005 Forbes, 2010, COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer, Nucleic Acids Res, 39, D945, 10.1093/nar/gkq929 Duncavage, 2012, Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia, Mod Pathol, 25, 795, 10.1038/modpathol.2012.29 Becker, 2013, Deep ion sequencing of amplicon adapter ligated libraries: a novel tool in molecular diagnostics of formalin fixed and paraffin embedded tissues, J Clin Pathol, 10.1136/jclinpath-2013-201549 Beadling, 2013, Combining highly multiplexed PCR with semiconductor-based sequencing for rapid cancer genotyping, J Mol Diagn, 15, 171, 10.1016/j.jmoldx.2012.09.003 Singh, 2013, Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes, J Mol Diagn, 15, 607, 10.1016/j.jmoldx.2013.05.003 Wood, 2010, Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens, Nucleic Acids Res, 38, e151, 10.1093/nar/gkq510 Hayes, 2013, Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation, Genomics, 102, 174, 10.1016/j.ygeno.2013.04.006 Medvedev, 2009, Computational methods for discovering structural variation with next-generation sequencing, Nat Methods, 6, S13, 10.1038/nmeth.1374 Duan, 2013, Comparative studies of copy number variation detection methods for next-generation sequencing technologies, PLoS One, 8, e59128, 10.1371/journal.pone.0059128 Michaux, 2000, MLL amplification in myeloid leukemias: a study of 14 cases with multiple copies of 11q23, Genes Chromosomes Cancer, 29, 40, 10.1002/1098-2264(2000)9999:9999<::AID-GCC1003>3.3.CO;2-L Rayeroux, 2009, Gene amplification in myeloid leukemias elucidated by fluorescence in situ hybridization, Cancer Genet Cytogenet, 193, 44, 10.1016/j.cancergencyto.2009.04.006 Barber, 2004, Amplification of the ABL gene in T-cell acute lymphoblastic leukemia, Leukemia, 18, 1153, 10.1038/sj.leu.2403357